<i id='0C5711F7A5'><strike id='0C5711F7A5'><tt id='0C5711F7A5'><pre id='0C5711F7A5'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies 
Cigna wins case to block Amy Bricker's move to CVS 
Hepatitis C has a cure — but many Americans still lack access to it 
Pharma companies must ensure equitable access to obesity drugs 
Affirmative action in medical school literally saved lives 
Readout LOUD podcast: Venture capital turmoil, obesity drug competition 
Drug repurposing or repositioning? The language matters 
Statins may not be needed by millions of people, study suggests 
Medical records are filled with copy 
New report analyzes digital physical therapy solutions' effectiveness 
Tori Bowie and the unacceptable rates of Black maternal death 
How the BIOSECURE Act is already affecting U.S., Chinese life science firms 
Malaria cases in Florida and Texas: Here’s what you need to know 
In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug 
Sports medicine is finally prioritizing gender equality 
